Osteopore有限公司已与Accelerate Technologies私人有限公司达成一项独家技术许可协议，旨在引进并商业化一项创新的再生技术。该协议的签署标志着Osteopore在生物材料和组织工程领域的战略布局进一步深化，有望借助Accelerate Technologies的研发实力，拓展其在医疗再生领域的产品管线。这项合作将为双方带来协同效应，加速新型再生技术的临床应用和市场推广。
Osteopore有限公司已与Accelerate Technologies私人有限公司达成一项独家技术许可协议，旨在引进并商业化一项创新的再生技术。该协议的签署标志着Osteopore在生物材料和组织工程领域的战略布局进一步深化，有望借助Accelerate Technologies的研发实力，拓展其在医疗再生领域的产品管线。这项合作将为双方带来协同效应，加速新型再生技术的临床应用和市场推广。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.